• Tidak ada hasil yang ditemukan

BAB VII SIMPULAN DAN SARAN

7.2 Saran

1. Perlu dilakukan penelitian lebih lanjut terhadap minyak kelapa tradisional dan minyak sawit yang dipanaskan untuk mengetahui kestablan dari kedua minyak terhadap pemanasan.

83

2. Perlu dilakukan penelitian lebih lanjut terhadap minyak kelapa dan minyak sawit yang digunakan untuk menggoreng bahan makanan dalam hubungannya dengan profil lipid.

3. Perlu dilakukan penelitian pada manusia untuk mengetahui dampak dari minyak kelapa dan minyak sawit terhadap profil lipid manusia sehingga nantinya bisa diterapkan terhadap manusia.

84

DAFTAR PUSTAKA

Adam, S. K., Soelaiman, I. N., Umar, N. A., Mokhtar, N., Mohamed, N., &

Jaarin, K. 2008. Effects of repeatedly heated palm oil on serum lipid profile, lipid peroxidation and homocysteine levels in a post-menopausal rat model. Mcgill Journal of Medicine, 11(2), 145-151.

Almatsier, S. 2009. Prinsip Dasar Ilmu Gizi. Cetakan VII. Jakarta: penerbit PT.

Gramedia Pustaka Utama. p.51-69.

Al-Shudiefat, A.A.R.,Sharma, A.K., Bagchi, A.K., Dhigra, S., Singal, P.K. 2013.

Oleic acid mitigates TNF-α-induced oxidative stress in rat cardiomyocites.

Molecular and Cellular Biochemistry, 372 (1-2): 75-82.

Aminah, S. Dan Iswono, J.T. 2010. Praktek Penggorengan dan Mutu Minyak Goreng Sisa pada Rumah Tangga di RT V RW III Kedungmundu Tembalang Semarang. Available from : URL: http://jurnal.unimus.ac.id.

Accessed February 23th 2016.

Anonim. 2012. Cara Membuat Minyak Kelapa Sendiri. Available at : URL:

http://www.wedaran.com/6399. Accesed June 21st 2016

Arking, R. 2006. Biology of aging: observations and principles. Oxford University Press.

Mansur, A. 2013. Pembuatan Minyak Kelapa Tradisional. Available from : URL:

https: // aswadmansur.wordpress.com/2013. Accesed June 21st 2016 Badan Pusat Statistik. Rata-rata Konsumsi Kalori (Kkal) per Kapita Sehari

Menurut Kelompok Makanan 2002-2011. 2011; Available at : URL:

http://www.bps. go.id. Accessed October 23th 2015.

Bays, H. E.,Toth, P. P., Kris-Etherton, P. M., Abate, N., Aronne, L.J., Brown, W. V., ... &Samuel, V. T. 2013. Obesity, adiposity, and dyslipidemia : a consensus statement from National Lipid Association. Journal of clinical lipidology, 7(4), 304-383.

Berry, S.E. 2009. Triacylglycerol structure and interesterification of palmitic and stearic acid rich fats: an overview and implications for cardiovascular disease. Nutrition Research Reviews, 22(1), 3.

Botham, K. M., Mayes, P. A. 2006. Cholesterol synthesis, transport and excretion.

In: Murray RK editor. Harper’s Illustrated Biochemestry .p:219-30.

85

Carandang, V. E. 2008. Health Benefits of Virgin Coconut Oil Explained.

Available from: www.pcrdf.org/artimages%5CVCO.doc. Accessed March 17th 2016.

Chan, D.C., Barrett, P.H.R, Ooi, E. M., Ji, J., Chan, D.T., and Watts, G.F. 2009.

Very-low density lipoprotein metabolism dan plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-1 kinetics in obese dan non-obese men. The Journal of Clinical Endocrinology and Metabolism, 94(3),989–997.

Chen, X., Xun, K., Chen, L., & Wang, Y. 2009. TNF‐α, a potent lipid metabolism regulator. Cell biochemistry and function, 27(7), 407-416.

Choe, E., & Min, D. B. 2007. Chemistry of deep‐fat frying oils. Journal of food science, 72(5), R7

Colcear, D. 2006. Study Regarding The Hipocholesterolemiant Effect Of isolavonts Supplements Obtained from Trifalium Pretense. Notulae Botanicae Horti Agrobotanici Cluj-Napoca, 34, 88.

Dayrit, F. M. 2015. The properties of Lauric acid and their significance in coconut oil. Journal of the American Oil Chemists' Society, 92(1), 1-15.

Depkes, 2006. Penurunan Kolesterol. Available at:http://www.litbang.depkes.go.

id/actual/klipinh/. Accesed on October, 27th 2015.

Durstine, J. L. 2006. Action Plan For High Cholesterol . Human Kinetics.

Eszy, M. S., Sastri, S., & Masri, M. 2014. Pengaruh Pemberian Diet Tinggi Minyak Sawit terhadap Kadar Malondialdehid Darah Tikus Wistar. Jurnal Kesehatan Andalas, 3(3).

Expert Panel on Detection, E. 2001. Executive summary of the Third Report of National Cholesterol Education Program (NCEP) expert panel on detection, evaluation dan treatment of high blood cholesterol in adults (Adult treatment Panel III). Jama, 285(19), 2486.

Fadhilla, R.A. 2008. Analisis Kepuasan Dan Loyalitas Konsumen Minyak Goreng Kemasan Merk Bimoli (Kasus: Rumah Tangga di Kota Bogor). Available from: www.repository.ipb.ac.id/bitstream/handle/12456789/A08raf.pdf.

Hal: 12, 14-16. Accessed December 3th 2015

Goldman, R., & Klatz, R. 2007. The New Anti-Aging Revolution. Australasian Edition. Malaysia : Advantage Quest Pubilication. p 15-17.

Grundy, S. M. 2006. Nutrition in the Management of Disorder of Serum Lipids And Lipoprotein. In Modern Nutrition in Health dan Disease. 10th Ed.

p1076-1094. Lippincott Williams dan Wilkins, Baltimore.

Guyton and Hall. 2007. Lipid Metabolism. Textbook of Medical Physiology.Eleventh Edition. Philadelphia: Elsevier Saunders.

Hambali, E., Mujdalifah, S., Tambunan, A. H., Pattiwiri, A. W., dan Hendroko, R.

2007. Teknologi bioenergi. AgroMedia

Harvey, R and Ferrier, D. 2011. Lippicott’s Illustrated Reviews: Biochemistry.

5th edition. Philadelphia: Wolter Kluwer. P. 173-244.

Irwanto, J. 2012. Pencernaan dan Absorbsi. Available from: www.scrib.com/

doc/91778777/Pencernaan-Dan-Absorbsi. Accessed December 23th 2015.

Junaidi. 2009. Metabolisme Lemak. Available from: http//www-Junaidi. Blogspot.

com/2009/06/ hubungan-antara-metabolisme-lemak. Accessed : October 24, 2015.

Kemenkes, R. I. 2014. Infodatin Pusat Data dan Informasi Kementrian Kesehatan RI: Situasi dan analisis Diabetes Mellitus. Jakarta: Kemenkes RI.

Kersshaw, E. E., & Flier, J. S. 2004. Adipose Tissue as an Endocrine Organ. The Journal of Clinical Endocrinology and Metabilism,89(6), 2548-2556.

Kusumawati, D. 2004. Bersahabat dengan Hewan Coba. Yogyakarta : Gajah Mada University Press.

Liu Di, Xu Jia-Ying, &Jiao Yang. 2012. Effects of Puer Tea Aqueous Extracts and Green Tea Polyphenols on the Expression of Longevity Related Gene CETP. Chinese Journal of Gerontology, 2012-02.

McKenney, J. M., Jones, P. H., Bays, H. E., Knopp, R. H., Kashyap, M. L., Ruoff , G.

E., &McGovern, M. E. 2007. Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study). Atherosclerosis, 192(2), 432- 437.

Murray, R. K., Granner, D. K., Mayes, P. A., Rodwell, V. W. 2009. Biokimia Harper. Edisi 27. Jakarta : Penerbit EGC. Hal: 141, 143, 194, 195, 234.

Ong, A. S., & Goh, S. H. 2002. Palm oil: a healthful and cost-effective dietary component. Food & Nutrition Bulletin, 23(1), 11-22.

Pahan, I. 2008. Panduan Lengkap Kelapa Sawit Manajemen Agribisnis Dari Hulu Hingga Hilir, Cetakan ke 5. Jakarta: Penerbit Penebar Swadaya. p.78, 81.

87

Pangkahila, W. 2007. Anti Aging Medicine : Memperlambat Penuaan meningkatkan Kualitas Hidup. Jakarta : PT Kompas Media Nusantara. p.l 2.

Pangkahila, W. 2011. Anti Aging Tetap Muda dan Sehat. Jakarta: Kompas. p.151- 192.

Penapisan Farmakolgi, Pengujian Fitokimia dan Pengujian Klinik.

Pengembangandan Pemanfaatan bahan alam, 1991.

Pocock. 2008. Clinical Trial: A Practical Approach. Chichester : John Willey dan Sons.p. 127-128.

Rachmat, S., & Wiramihardja, K. K. 2009. Obesitas Permasalahan dan Terapi Praktis.

Reiner, Z., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M. R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., Erdine, S., Halcox, J., Hobbs, R., Jkjekshus, J., Filardi, P. P., Riccardi, G., Storey, R. F. 2011. Wood D for The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). ESC/EAS Guidelines for the management of dyslipidaemias. Europe Heart Journal, 32:1769-818.

Rorong, J., Aritonang, H. F., & Ranti, F. P. 2008. SINTESIS METIL ESTER

ASAM LEMAK DARI MINYAK KELAPA HASIL

PEMANASAN. CHEMISTRY PROGRESS, 1(1), 9-18.

Santoso, M., & Setiawan, T. 2005. Penyakit Jantung Koroner.Cermin Dunia Kedokteran No 147,p:6-9.

Sartika, R. A. D. 2009. Pengaruh Suhu dan Lama Proses Menggoreng (Deep Frying) Terhadap pembentukan Asam Lemak Trans. Makara, Sains, Vol.

13, No. 1, 23-28.

Silalahi, J., & Nurbaya, S. 2011. Komposisi, distribusi dan sifat aterogenik asam lemak dalam minyak kelapa dan kelapa sawit. Journal of the Indonesian Medical Association, 61, 453-457.

Smith, J. B., Mangkoewidjojo, S. 1998. Pemeliharaan Pembiakan dan Penggunaan Hewan Percobaan Di Daerah Tropis. Jakarta: UI Press.

Sunarsih, E.S., Prasetyastuti. 2008. Pengaruh Pemberian Juice Lidah Buaya terhadap Kadar Lipid Peroksida (MDA) pada Tikus Jantan Hiperlipidemia.

Majalah Obat Tradisional. 45(13); 145-152.

Suryaatmaja, M., &Silman, E. 2006. Diagnosa Laboratorium Kelainan LemakDarah.

Cermin Dunia Kedokteran. Available from:http//www.kalbe.co.id/ files/ cdk/

files/06. Diagnosa Lab. Kelainan Lemak Darah.pdf. Accessed : October 24th 2015.

Suryawati, S. dan Santoso, B. 1991. Antihiperlipidemia. Pedoman Pengujian dan Pengembangan Fitofarmaka. Jakarta: Kelompok Kerja Ilmiah PHYTO MEDICA. H 41-43.

Susiyati, N. 2015. Pemberian Minyak Sawit yang diproses dengan Cara Pemurnian Multi Proses (PMP) dapat memperbaiki Profil Lipid Tikus Jantan Putih (Albino Rat) Dislipidemia. Penelitian pendahuluan.

Takeuchi, H., Sekine, S., Kojima, K., Aoyama, T. The Application of Medium- Chain Fatty Acids: Edible Oil With A Suppressing Effect on Body Fat Accumulation. Asia Pacific Journal of Clinical Nurtrition. 2008; 17 (S1):

320-323.Available from: www.apjn.nhri.org.tw/server/apjn/volume17/

1/320-32519-5.pdf. Accessed march 16th 2016.

Umi, K. 2007. Skripsi Pengaruh Pemberian Jus Lidah Buaya Terhadap Kadar Kolesterol HDL dan LDL serum tikus putih Hiperkolesterolemia : Jurusan Biologi MIPA Universitas Negeri Semarang.

Wahyudi, A. 2009. “Metabolisme Kolesterol Hati: Khasit Ramuan Jati Belanda (Guazuma ulmifolia Lamk) dalam Mengatur Konsentrasi Kolesterol Selular”

(tesis). Bogor : Institut Pertanian Bogor.

Wawan, P., 2011. Kelapa Sawit. Available from: www.puputwawan.wordpress.

com/2011/06/25/botani-kelapa-sawit/. Accessed November 29th 2015.

89

Lampiran 1

Kelaikan etik (Ethical clearance)

Lampiran 2

Tabel Konversi Perhitungan Dosis Laurence & Bacharach

TABEL KONVERSI PERHITUNGAN DOSIS LAURENCE & BACHARACH (Kusumawati, 2004)

Mencit 20 gr

Tikus 200gr

Marmot 400 gr

Kelinci 1,5 kg

Kucing 2 kg

Kera 4 kg

Anjing 12 kg

Manusia 70 kg Mencit

20 gr

1,0 7,0 12,25 27,8 29,7 64,1 124,2 387,9 Tikus

200 gr

0,14 1,0 1,74 3,9 4,2 9,2 17,8 56,0

Marmot 400 gr

0,08 0,57 1,0 2,25 2,4 5,2 10,2 31,5

Kelinci 1,5 kg

0,04 0,25 0,44 1,0 1,08 2,4 4,5 14,2

Kucing 2 kg

0,03 0,23 0,41 0,92 1,0 2,2 4,1 13,0

Kera 4 kg

0,016 0,11 0,19 0,42 0,45 1,0 1,9 6,1

Anjing 12 kg

0,008 0,06 0,1 0,22 0,24 0,52 1,0 3,1

Manusia 70 kg

0,0026 0,018 0,031 0,07 0,076 0,16 0,32 1,0

91

Lampiran 3 Foto-foto Penelitian

Kandang tikus beserta tempat minumnya

Pengambilan darah tikus dengan pipet mikrokapiler di

medial kantus pada plexus venosus retroorbitalis

Anestesi ketamine+xylazin pada vastus lateralis sebelum diambil

darah

Pemberian minyak kelapa atau minyak sawit dengan zonde

lambung

Spuit, pipet mikro kapiler untuk ambil darah, 2 botol

berisi minyak sawit dan minyak kelapa yang sudah

dipanaskan, zonde lambung, anestesi ketamine dan xylazin,

tabung EDTA untuk menampung darah

Lampiran 4

Laporan hasil uji analisis minyak sawit

93

Lampiran 5

Hasil analisis deskriptif data pre test

Report

Kolesterol Total (mg/dl)

Kelompok N Mean Std. Deviation Median Minimum Maximum

P0 (Kontrol) 7 222.7571 9.41636 220.3500 210.42 238.32

P1 (Minyak sawit) 7 222.2686 5.49592 221.8700 213.28 230.14

P2 (Minyak Kelapa) 7 218.5986 6.12573 219.1500 211.18 230.21

Total 21 221.2081 7.10887 220.2700 210.42 238.32

Report

Trigliserida (mg/dl)

Kelompok N Mean Std. Deviation Median Minimum Maximum

P0 (Kontrol) 7 152.5143 7.45488 155.1300 140.28 160.92

P1 (Minyak sawit) 7 152.5700 5.23395 150.9200 144.92 159.34

P2 (Minyak Kelapa) 7 156.1643 5.58175 156.3200 149.44 167.20

Total 21 153.7495 6.10733 155.1300 140.28 167.20

Report

HDL (mg/dl)

Kelompok N Mean Std. Deviation Median Minimum Maximum

P0 (Kontrol) 7 31.4443 3.01309 30.2800 28.75 37.43

P1 (Minyak sawit) 7 29.0214 .89706 29.4300 27.34 29.94

P2 (Minyak Kelapa) 7 29.5843 1.59115 29.4000 27.43 32.54

Total 21 30.0167 2.20227 29.5500 27.34 37.43

Report

LDL (mg/dl)

Kelompok N Mean Std. Deviation Median Minimum Maximum

P0 (Kontrol) 7 93.8471 2.57493 94.2400 90.35 98.10

P1 (Minyak sawit) 7 93.6114 4.31078 93.1000 88.14 98.74

P2 (Minyak Kelapa) 7 92.5886 2.39103 92.9300 89.14 95.25

Total 21 93.3490 3.09716 93.1000 88.14 98.74

95

Lampiran 6

Hasil analisis deskriptif data post test

Report

Kolesterol Total (mg/dl)

Kelompok N Mean Std. Deviation Median Minimum Maximum

P0 (Kontrol) 7 224.4257 8.98225 224.3800 210.43 239.32

P1 (Minyak sawit ) 7 164.8700 6.53971 166.3100 150.87 170.32 P2 (Minyak Kelapa) 7 148.2886 2.38760 148.7600 143.89 150.98

Total 21 179.1948 34.07236 166.3100 143.89 239.32

Report

Trigliserida (mg/dl)

Kelompok N Mean Std. Deviation Median Minimum Maximum

P0 (Kontrol) 7 152.3914 7.45737 152.2400 139.73 159.92

P1 (Minyak sawit ) 7 127.9943 1.98255 127.4300 125.89 131.64 P2 (Minyak Kelapa) 7 112.7414 3.38310 112.8400 108.93 117.83

Total 21 131.0424 17.35787 127.4300 108.93 159.92

Report

HDL (mg/dl)

Kelompok N Mean Std. Deviation Median Minimum Maximum

P0 (Kontrol) 7 29.2800 .80678 29.6500 27.84 30.22

P1 (Minyak sawit) 7 37.4343 2.16729 37.9800 32.75 39.08

P2 (Minyak Kelapa) 7 54.6500 1.47516 54.9800 52.93 56.82

Total 21 40.4548 10.93999 37.9800 27.84 56.82

Report

LDL (mg/dl)

Kelompok N Mean Std. Deviation Median Minimum Maximum

P0 (Kontrol) 7 94.9786 2.64682 94.8800 92.09 99.72

P1 (Minyak sawit) 7 69.3143 1.11070 69.8300 67.84 70.72

P2 (Minyak Kelapa) 7 47.3914 1.25446 47.3400 45.20 48.77

Total 21 70.5614 20.00136 69.8300 45.20 99.72

Lampiran 7

Uji normalitas data Data Pre Test

Tests of Normality

Kelompok

Kolmogorov-Smirnova Shapiro-Wilk Statistic df Sig. Statistic df Sig.

Kolesterol Total (mg/dl) Kontrol .172 7 .200* .971 7 .907

P1 (Minyak sawit) .158 7 .200* .976 7 .936

P2 (Minyak Kelapa) .254 7 .192 .913 7 .415

Trigliserida (mg/dl) Kontrol .209 7 .200* .934 7 .590

P1 (Minyak sawit) .195 7 .200* .948 7 .711

P2 (Minyak Kelapa) .284 7 .093 .885 7 .249

HDL (mg/dl) Kontrol .308 7 .044 .815 7 .058

P1 (Minyak sawit) .247 7 .200* .896 7 .306

P2 (Minyak Kelapa) .223 7 .200* .936 7 .600

LDL (mg/dl) Kontrol .149 7 .200* .975 7 .930

P1 (Minyak sawit) .193 7 .200* .909 7 .390

P2 (Minyak Kelapa) .199 7 .200* .920 7 .471

a. Lilliefors Significance Correction

*. This is a lower bound of the true significance.

Data Post Test

Tests of Normality

Kelompok

Kolmogorov-Smirnova Shapiro-Wilk Statistic df Sig. Statistic df Sig.

Kolesterol Total (mg/dl) Kontrol .147 7 .200* .985 7 .980

P1 (Minyak sawit) .304 7 .050 .764 7 .218

P2 (Minyak Kelapa) .150 7 .200* .939 7 .632

Trigliserida (mg/dl) Kontrol .218 7 .200* .908 7 .383

P1 (Minyak sawit) .183 7 .200* .919 7 .459

P2 (Minyak Kelapa) .191 7 .200* .936 7 .603

HDL (mg/dl) Kontrol .248 7 .200* .926 7 .517

P1 (Minyak sawit) .298 7 .061 .733 7 .508

P2 (Minyak Kelapa) .160 7 .200* .933 7 .574

LDL (mg/dl) Kontrol .228 7 .200* .915 7 .432

P1 (Minyak sawit) .250 7 .200* .903 7 .352

P2 (Minyak Kelapa) .176 7 .200* .929 7 .538

a. Lilliefors Significance Correction

*. This is a lower bound of the true significance.

97

Lampiran 8

Uji homogenitas data pre test

Test of Homogeneity of Variance

Levene Statistic df1 df2 Sig.

Kolesterol Total (mg/dl) Based on Mean 1.384 2 18 .276

Based on Median .922 2 18 .416

Based on Median and with adjusted df

.922 2 14.736 .420

Based on trimmed mean 1.343 2 18 .286

Trigliserida (mg/dl) Based on Mean 1.104 2 18 .353

Based on Median .544 2 18 .590

Based on Median and with adjusted df

.544 2 16.351 .591

Based on trimmed mean 1.045 2 18 .372

HDL (mg/dl) Based on Mean 3.173 2 18 .066

Based on Median 1.061 2 18 .367

Based on Median and with adjusted df

1.061 2 9.418 .384

Based on trimmed mean 2.590 2 18 .103

LDL (mg/dl) Based on Mean 3.233 2 18 .063

Based on Median 2.439 2 18 .116

Based on Median and with adjusted df

2.439 2 15.385 .120

Based on trimmed mean 3.254 2 18 .062

Lampiran 9

Uji homogenitas data post test

Test of Homogeneity of Variance

Levene Statistic df1 df2 Sig.

Kolesterol Total (mg/dl) Based on Mean 1.936 2 18 .173

Based on Median 1.783 2 18 .197

Based on Median and with adjusted df

1.783 2 12.853 .207

Based on trimmed mean 1.860 2 18 .184

Trigliserida (mg/dl) Based on Mean 5.525 2 18 .313

Based on Median 5.350 2 18 .315

Based on Median and with adjusted df

5.350 2 9.853 .327

Based on trimmed mean 5.794 2 18 .311

HDL (mg/dl) Based on Mean 1.205 2 18 .323

Based on Median .624 2 18 .547

Based on Median and with adjusted df

.624 2 10.120 .555

Based on trimmed mean .971 2 18 .398

LDL (mg/dl) Based on Mean 1.559 2 18 .237

Based on Median 1.335 2 18 .288

Based on Median and with adjusted df

1.335 2 10.769 .303

Based on trimmed mean 1.360 2 18 .282

99

Lampiran 10

Analisis komparasi data pre test

ANOVA Sum of

Squares df Mean Square F Sig.

Kolesterol Total (mg/dl) Between Groups 72.336 2 36.168 .694 .513

Within Groups 938.385 18 52.133

Total 1010.722 20

Trigliserida (mg/dl) Between Groups 61.237 2 30.619 .805 .463

Within Groups 684.752 18 38.042

Total 745.989 20

HDL (mg/dl) Between Groups 22.509 2 11.254 2.720 .093

Within Groups 74.491 18 4.138

Total 97.000 20

LDL (mg/dl) Between Groups 6.267 2 3.133 .304 .742

Within Groups 185.581 18 10.310

Total 191.848 20

Lampiran 11

Analisis komparasi data post test

ANOVA

Sum of Squares df Mean Square F Sig.

Kolesterol Total (mg/dl) Between Groups 22443.613 2 11221.807 260.671 .000

Within Groups 774.895 18 43.050

Total 23218.508 20

Trigliserida (mg/dl) Between Groups 5599.983 2 2799.992 118.329 .000

Within Groups 425.930 18 23.663

Total 6025.913 20

HDL (mg/dl) Between Groups 2348.524 2 1174.262 468.198 .000

Within Groups 45.145 18 2.508

Total 2393.668 20

LDL (mg/dl) Between Groups 7942.208 2 3971.104 1214.035 .000

Within Groups 58.878 18 3.271

Total 8001.086 20

101

Lampiran 12

Multiple Comparisons

Multiple Comparisons

LSD

Dependent

Variable (I) Kelompok (J) Kelompok

Mean Difference (I-J)

Std.

Error Sig.

95% Confidence Interval Lower Bound

Upper Bound Kolesterol Total

(mg/dl)

Kontrol P1 (Minyak sawit)

59.55571* 3.50712 .000 52.1875 66.9239

P2 (Minyak Kelapa)

76.13714* 3.50712 .000 68.7689 83.5053

P1 (Minyak sawit)

Kontrol -59.55571* 3.50712 .000 -66.9239 -52.1875

P2 (Minyak Kelapa)

16.58143* 3.50712 .000 9.2132 23.9496

P2 (Minyak Kelapa)

Kontrol -76.13714* 3.50712 .000 -83.5053 -68.7689

P1 (Minyak sawit)

-16.58143* 3.50712 .000 -23.9496 -9.2132

Trigliserida (mg/dl)

Kontrol P1 (Minyak sawit)

24.39714* 2.60015 .000 18.9344 29.8599

P2 (Minyak Kelapa)

39.65000* 2.60015 .000 34.1873 45.1127

P1 (Minyak sawit )

Kontrol -24.39714* 2.60015 .000 -29.8599 -18.9344

P2 (Minyak Kelapa)

15.25286* 2.60015 .000 9.7901 20.7156

P2 (Minyak Kelapa)

Kontrol -39.65000* 2.60015 .000 -45.1127 -34.1873 P1 (Minyak

sawit)

-15.25286* 2.60015 .000 -20.7156 -9.7901

HDL (mg/dl) Kontrol P1 (Minyak sawit)

-8.15429* .84651 .000 -9.9327 -6.3758

P2 (Minyak Kelapa)

-25.37000* .84651 .000 -27.1485 -23.5915

P1 (Minyak sawit)

Kontrol 8.15429* .84651 .000 6.3758 9.9327

P2 (Minyak Kelapa)

-17.21571* .84651 .000 -18.9942 -15.4373

P2 (Minyak Kelapa)

Kontrol 25.37000* .84651 .000 23.5915 27.1485 P1 (Minyak

sawit)

17.21571* .84651 .000 15.4373 18.9942

LDL (mg/dl) Kontrol P1 (Minyak sawit)

25.66429* .96673 .000 23.6333 27.6953

P2 (Minyak Kelapa)

47.58714* .96673 .000 45.5561 49.6182

P1 (Minyak sawit)

Kontrol -25.66429* .96673 .000 -27.6953 -23.6333 P2 (Minyak

Kelapa)

21.92286* .96673 .000 19.8918 23.9539

P2 (Minyak Kelapa)

Kontrol -47.58714* .96673 .000 -49.6182 -45.5561 P1 (Minyak

sawit)

-21.92286* .96673 .000 -23.9539 -19.8918

*. The mean difference is significant at the 0.05 level.

103

Lampiran 13

Analisis efek perlakuan Kelompok Kontrol

Paired Samples Test Paired Differences

t df

Sig. (2- tailed) 95% Confidence

Interval of the Difference

Mean

Std.

Deviation

Std. Error

Mean Lower Upper Pair 1 Kolesterol Total Pretest

(mg/dl) - Kolesterol Total Posttest (mg/dl)

-1.66857 2.01947 .76329 -3.53627 .19912 -2.186 6 .071

Pair 2 Trigliserida Pretest (mg/dl) - Trigliserida Posttest (mg/dl)

.12286 1.89821 .71745 -1.63269 1.87841 .171 6 .870

Pair 3 HDL Pretest (mg/dl) - HDL Postetst (mg/dl)

2.16429 2.66869 1.00867 -.30384 4.63242 2.146 6 .076

Pair 4 LDL Pretest (mg/dl) - LDL Posttest (mg/dl)

-1.13143 .75830 .28661 -1.83274 -.43012 -3.948 6 .008

Kelompok P1 (Minyak Bimoli)

Paired Samples Test Paired Differences

t df

Sig. (2- tailed) 95% Confidence Interval

of the Difference

Mean

Std.

Deviation

Std. Error

Mean Lower Upper

Pair 1 Kolesterol Total Pretest (mg/dl) - Kolesterol Total Posttest (mg/dl)

57.39857 10.22421 3.86439 47.94276 66.85438 14.853 6 .000

Pair 2 Trigliserida Pretest (mg/dl) - Trigliserida Posttest (mg/dl)

24.57571 5.84129 2.20780 19.17343 29.97800 11.131 6 .000

Pair 3 HDL Pretest (mg/dl) - HDL Postetst (mg/dl)

-8.41286 1.41061 .53316 -9.71745 -7.10826 -15.779 6 .000

Pair 4 LDL Pretest (mg/dl) - LDL Posttest (mg/dl)

24.29714 4.89843 1.85143 19.76685 28.82744 13.123 6 .000

Dokumen terkait